JUSH
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Jushi Holdings Inc. publishes a filing, an earnings call transcript or a press release.
Get JUSH alertsMichelle O. Mosier is recorded as CFO at Jushi Holdings Inc. (JUSH). The newest filing on record that lists Michelle O. Mosier as CFO at Jushi Holdings Inc. (JUSH) is dated May 11, 2026. Hamilton Beach Brands Holding Co reported in an 8-K filed January 17, 2023 that Michelle O. Mosier resigned as Senior Vice President, Chief Financial Officer and Treasurer, effective January 13, 2023. Hamilton Beach Brands Holding Co reported in an 8-K filed November 16, 2022 that Michelle O. Mosier resigned as Senior Vice President, Chief Financial Officer and Treasurer, effective January 13, 2023. The proxy statement of Jushi Holdings Inc. reports total compensation of $769,599 for Michelle O. Mosier in fiscal 2025, including a base salary of $425,016. Disclosed compensation is on record for 4 fiscal years. Michelle O. Mosier has spoken on 2 earnings calls across 1 company, most recently for Jushi Holdings Inc. on October 28, 2026. Jushi Holdings Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Jushi Holdings Inc. includes James Cacioppo (CEO and Board Member), Michelle Mosier (CFO and Chief Accounting Officer), Todd West (COO) and 5 others.
“Michelle O. Mosier has resigned as Senior Vice President, Chief Financial Officer and Treasurer of Hamilton Beach Brands Holding Company (the "Company"), effective January 13, 2023.”
“On November 15, 2022, Michelle O. Mosier notified Hamilton Beach Brands Holding Company (the "Company") of her decision to resign as Senior Vice President, Chief Financial Officer and Treasurer of the Company, effective January 13, 2023.”
“I will provide more detail on our third quarter results. Revenue for the third quarter increased $4.8 million to $70.5 million, compared to $65.7 million in the prior quarter.”
“I will now provide more detail on our second quarter results. As Jim stated, revenue for the second quarter increased $6.3 million to $71.3 million compared to $65 million in the prior quarter.”
Start not stated–present
Last confirmed May 11, 2026
JUSH
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Jushi Holdings Inc. (JUSH) | CFO | $425,016 | $769,599 |
| 2024 | Jushi Holdings Inc. (JUSH) | CFO | $414,599 | $710,219 |
| 2023 | Jushi Holdings Inc. (JUSH) | CFO | $383,348 | $753,410 |
| 2022 | Jushi Holdings Inc. (JUSH) | CFO | — | — |